A functional role of nmda receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination

GLIA

Volumn 61, Issue 5, 2013, Pages 732-749

  Li, Cui ^a,b   Xiao, Lin ^a   Liu, Xiuyun ^a   Yang, Wenjing ^a   Shen, Weiran ^a   Hu, Chun ^a   Yang, Guang ^a   He, Cheng ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cuprizone Model; Differentiation; Myelination; Nmdar; Opcs; Remyelination

Indexed keywords

GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; MAMMALIAN TARGET OF RAPAMYCIN; MYELIN PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RAPAMYCIN; DIZOCILPINE MALEATE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REMYELINIZATION; RNA INTERFERENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; MALE; MOUSE; MYELIN SHEATH; NEURAL STEM CELL; NEWBORN; PHYSIOLOGY;

ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; CELLS, CULTURED; DIZOCILPINE MALEATE; MALE; MICE; MICE, INBRED C57BL; MYELIN SHEATH; NEURAL STEM CELLS; OLIGODENDROGLIA; RATS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84882740468     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22469     Document Type: Article

References (71)

1. Agresti C, Meomartini M, Amadio S, Ambrosini E, Volonte C, Aloisi F, Visentin S. ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: Involvement of metabotropic P2 receptors. Brain Res Rev 2005;48:157-165.
2. Arnett HA, Fancy SPJ, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJM, Stiles CD. bHLH Transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 2004;306: 2111-2115.
3. Bakker DA, Ludwin SK. Blood-brain barrier permeability during Cuprizoneinduced demyelination. Implications for the pathogenesis of immunemediated demyelinating diseases. J Neurol Sci 1987;78:125-137.
4. Barres BA, Jacobson MD, Schmid R, Sendtner M, Raff MC. Does oligodendrocyte survival depend on axons? Current Biol 1993;3:489-497.
5. Barres BA, Koroshetz WJ, Swartz KJ, Chun LLY, Corey DP. Ion channel expression by white matter glia: The O-2A glial progenitor cell. Neuron 1990;4:507-524.
6. Barth TM, Grant ML, Schallert T. Effects of MK-801 on recovery from sensorimotor cortex lesions. Stroke 1990;21(11 Suppl):III153-III157.
7. Berger T, Walz W, Schnitzer J, Kettenmann H. GABA- and glutamateactivated currents in glial cells of the mouse corpus callosum slice. J Neurosci Res 1992;31:21-27.
8. Billiards SS, Haynes RL, Folkerth RD, Borenstein NS, Trachtenberg FL, Rowitch DH, Ligon KL, Volpe JJ, Kinney HC. Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol 2008;18: 153-163.
9. Bottenstein JE, Hunter SF, Seidel M. CNS neuronal cell line-derived factors regulate gliogenesis in neonatal rat brain cultures. J Neurosci Res 1988;20: 291-303.
10. Butt AM. Neurotransmitter-mediated calcium signalling in oligodendrocyte physiology and pathology. Glia 2006;54:666-675.
11. Carpenter-Hyland EP, Chandler LJ. Adaptive plasticity of NMDA receptors and dendritic spines: Implications for enhanced vulnerability of the adolescent brain to alcohol addiction. Pharmacol Biochem Behav 2007;86:200-208.
12. Chan JR, Watkins TA, Cosgaya JM, Zhang C, Chen L, Reichardt LF, Shooter EM, Barres BA. NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron 2004;43:183-191.
13. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 2000;20:6404-6412.
14. Chang A, Tourtellotte WW, Rudick R, Trapp BD. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 2002; 346:165-173.
15. Coyle J, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993;262:689-695.
16. De Biase LM, Kang SH, Baxi EG, Fukaya M, Pucak ML, Mishina M, Calabresi PA, Bergles DE. NMDA receptor signaling in oligodendrocyte progenitors is not required for oligodendrogenesis and myelination. J Neurosci 2011;31: 12650-12662.
17. Demerens C, Stankoff B, Logak M, Anglade P, Allinquant B, Couraud F, Zalc B, Lubetzki C. Induction of myelination in the central nervous system by electrical activity. Proc Natl Acad Sci USA 1996;93:9887-9892.
18. Dugas JC, Tai YC, Speed TP, Ngai J, Barres BA. Functional genomic analysis of oligodendrocyte differentiation. J Neurosci 2006;26:10967-10983.
19. Etxeberria A, Mangin J-M, Aguirre A, Gallo V. Adult-born SVZ progenitors receive transient synapses during remyelination in corpus callosum. Nat Neurosci 2010;13:287-289.
20. Franklin RJ. Remyelination of the demyelinated CNS: The case for and against transplantation of central, peripheral and olfactory glia. Brain Res Bull 2002;57:827-832.
21. Gallo V, Zhou J, McBain C, Wright P, Knutson P, Armstrong R. Oligodendrocyte progenitor cell proliferation and lineage progression are regulated by glutamate receptor-mediated K{thorn} channel block. J Neurosci 1996;16:2659-2670.
22. Garraway SM, Xu Q, Inturrisi CE. siRNA-mediated knockdown of the NR1 subunit gene of the NMDA receptor attenuates formalin-induced pain behaviors in adult rats. J Pain 2009;10:380-390.
23. Ge WP, Yang XJ, Zhang Z, Wang HK, Shen W, Deng QD, Duan S. Long-term potentiation of neuron-glia synapses mediated by Ca2{thorn}-permeable AMPA receptors. Science 2006;312:1533-1537.
24. Groebe A, Clarner T, Baumgartner W, Dang J, Beyer C, Kipp M. Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum. Cerebellum 2009;8: 163-174.
25. Guardiola-Diaz HM, Ishii A, Bansal R. Erk1/2 MAPK and mTOR signaling sequentially regulates progression through distinct stages of oligodendrocyte differentiation. Glia 2012;60:476-486.
26. Gudz TI, Komuro H, Macklin WB. Glutamate stimulates oligodendrocyte progenitor migration mediated via an alphav integrin/myelin proteolipid protein complex. J Neurosci 2006;26:2458-2466.
27. Guo F, Maeda Y, Ko EM, Delgado M, Horiuchi M, Soulika A, Miers L, Burns T, Itoh T, Shen H, Lee E, Sohn J, Pleasure D. Disruption of NMDA receptors in oligodendroglial lineage cells does not alter their susceptibility to experimental autoimmune encephalomyelitis or their normal development. J Neurosci 2012;32:639-645.
28. Hamilton N, Vayro S, Wigley R, Butt AM. Axons and astrocytes release ATP and glutamate to evoke calcium signals in NG2-glia. Glia 2010;58:66-79.
29. Horner PJ, Gage FH. Regenerating the damaged central nervous system. Nature 2000;407:963-970.
30. Káradóttir R, Attwell D. Neurotransmitter receptors in the life and death of oligodendrocytes. Neuroscience 2007;145:1426-1438.
31. Káradóttir R, Cavelier P, Bergersen LH, Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005;438: 1162-1166.
32. Karadottir R, Hamilton NB, Bakiri Y, Attwell D. Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matter. Nat Neurosci 2008; 11:450-456.
33. Kondo A, Nakano T, Suzuki K. Blood-brain barrier permeability to horseradish peroxidase in twitcher and cuprizone-intoxicated mice. Brain Res 1987;425:186-190.
34. Kukley M, Kiladze M, Tognatta R, Hans M, Swandulla D, Schramm J, Dietrich D. Glial cells are born with synapses. FASEB J 2008;22:2957-2969.
35. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature 1993;364:535-537.
36. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA Antagonists. Science 2010;329:959-964.
37. Lin Sc, Bergles DE. Synaptic signaling between GABAergic interneurons and oligodendrocyte precursor cells in the hippocampus. Nat Neurosci 2004;7:24-32.
38. Lindner M, Heine S, Haastert K, Garde N, Fokuhl J, Linsmeier F, Grothe C, Baumgartner W, Stangel M. Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Neuropathol Appl Neurobiol 2008;34:105-114.
39. Manning SM, Talos DM, Zhou C, Selip DB, Park HK, Park CJ, Volpe JJ, Jensen FE. NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J Neurosci 2008; 28:6670-6678.
40. Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 2001;11:107-116.
41. Micu I, Jiang Q, Coderre E, Ridsdale A, Zhang L, Woulfe J, Yin X, Trapp BD, McRory JE, Rehak R, Zamponi GW, Wang W, Stys PK. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 2006;439:988-992.
42. Nacher J, McEwen BS. The role of N-methyl-D-asparate receptors in neurogenesis. Hippocampus 2006;16:267-270.
43. Nave K-A. Myelination and the trophic support of long axons. Nat Rev Neurosci 2010;11:275-283.
44. Patneau DK, Wright PW, Winters C, Mayer ML, Gallo V. Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor. Neuron 1994;12:357-371.
45. Pende M, Holtzclaw LA, Curtis JL, Russell JT, Gallo V. Glutamate regulates intracellular calcium and gene expression in oligodendrocyte progenitors through the activation of DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Proc Natl Acad Sci USA 1994;91:3215-3219.
46. Qi C, Zou H, Zhang R, Zhao G, Jin M, Yu L. Age-related differential sensitivity to MK-801-induced locomotion and stereotypy in C57BL/6 mice. Eur J Pharmacol 2008;580(1-2):161-168.
47. Rajan I, Cline HT. Glutamate receptor activity is required for normal development of tectal cell dendrites in vivo. J Neurosci 1998;18:7836-7846.
48. Rajasekharan S, Baker KA, Horn KE, Jarjour AA, Antel JP, Kennedy TE. Netrin 1 and Dcc regulate oligodendrocyte process branching and membrane extension via Fyn and RhoA. Development 2009;136:415-426.
49. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Rooney DL, Zhang M, Ihrig MM, McManus MT, Gertler FB, Scott ML, Van Parijs L. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003;33:401-406.
50. Salter MG, Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 2005;438:1167-1171.
51. Segovia KN, McClure M, Moravec M, Luo NL, Wan Y, Gong X, Riddle A, Craig A, Struve J, Sherman LS, Back SA. Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury. Annals Neurol 2008;63: 520-530.
52. Sidman R, Abervine J, Pierec E. Atlas of the mouse brain and spinal cord. Cambridge, MA: Harvard University Press, 1971.
53. Simons M, Trajkovic K. Neuron-glia communication in the control of oligodendrocyte function and myelin biogenesis. J Cell Sci 2006;119:4381-4389.
54. Sperber BR, McMorris FA. Fyn tyrosine kinase regulates oligodendroglial cell development but is not required for morphological differentiation of oligodendrocytes. J Neurosci Res 2001;63303-312.
55. Stevens B, Porta S, Haak LL, Gallo V, Fields RD. Adenosine A neuron-glial transmitter promoting myelination in the CNS in response to action potentials Neuron 2002;36:855-868.
56. Su Z, Yuan Y, Chen J, Zhu Y, Qiu Y, Zhu F, Huang A, He C. Reactive astrocytes inhibit the survival and differentiation of oligodendrocyte precursor cells by secreted TNF-alpha. J Neurotrauma 2011;28:1089-1100.
57. Swiech L, Perycz M, Malik A, Jaworski J. Role of mTOR in physiology and pathology of the nervous system. Biochim Biophys Acta 2008;1784:116-132.
58. Taveggia C, Feltri ML, Wrabetz L. Signals to promote myelin formation and repair. Nat Rev Neurol 2010;6:276-287.
59. Tyler WA, Gangoli N, Gokina P, Kim HA, Covey M, Levison SW, Wood TL. Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation. J Neurosci 2009;29:6367-6378.
60. Verkhratsky A, Kirchhoff F. NMDA receptors in glia. Neuroscientist 2007;13: 28-37.
61. Wake H, Lee PR, Fields RD. Control of local protein synthesis and initial events in myelination by action potentials. Science 2011;333:1647-1651.
62. Wang CC, Held RG, Chang SC, Yang L, Delpire E, Ghosh A, Hall BJ. A critical role for GluN2B-containing NMDA receptors in cortical development and function. Neuron 2011;72:789-805.
63. Wang JQ, Fibuch EE, Mao L. Regulation of mitogen-activated protein kinases by glutamate receptors. J Neurochem 2007;100:1-11.
64. Wigley R, Hamilton N, Nishiyama A, Kirchhoff F, Butt AM. Morphological and physiological interactions of NG2-glia with astrocytes and neurons. J Anatomy 2007;210:661-670.
65. Wolswijk G. Oligodendrocyte survival, loss and birth in lesions of chronicstage multiple sclerosis. Brain 2000;123:105-115.
66. Xiao L, Guo D, Hu C, Shen W, Shan L, Li C, Liu X, Yang W, Zhang W, He C. Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination. Glia 2012;60:1037-1052.
67. Xiao L, Hu C, Feng C, Chen Y. Switching of N-Methyl-d-aspartate (NMDA) Receptor-favorite intracellular signal pathways from ERK1/2 protein to p38 mitogen-activated protein kinase leads to developmental changes in NMDA neurotoxicity. J Biol Chem 2011;286:20175-20193.
68. Yang Z, Watanabe M, Nishiyama A. Optimization of oligodendrocyte progenitor cell culture method for enhanced survival. J Neurosci Methods 2005;149:50-56.
69. Yong VW, Cheung JCB, Uhm JH, Kim SU. Age-dependent decrease of process formation by cultured oligodendrocytes is augmented by protein kinase C stimulation. J Neurosci Res 1991;29:87-99.
70. Ziskin JL, Nishiyama A, Rubio M, Fukaya M, Bergles DE. Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci 2007;10: 321-330.
71. Zonouzi M, Renzi M, Farrant M, Cull-Candy SG. Bidirectional plasticity of calcium-permeable AMPA receptors in oligodendrocyte lineage cells. Nat Neurosci 2011;14:1430-1438.